Beaumont Financial Partners LLC Takes Position in Colgate-Palmolive Company (CL)

Beaumont Financial Partners LLC acquired a new stake in Colgate-Palmolive Company (NYSE:CL) during the first quarter, Holdings Channel reports. The institutional investor acquired 2,839 shares of the company’s stock, valued at approximately $208,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Advantage Investment Management LLC bought a new position in shares of Colgate-Palmolive Company during the fourth quarter worth about $104,000. Norway Savings Bank acquired a new stake in Colgate-Palmolive Company during the fourth quarter worth $110,000. Itau Unibanco Holding S.A. acquired a new stake in Colgate-Palmolive Company during the third quarter worth $118,000. Security Asset Management acquired a new stake in Colgate-Palmolive Company during the fourth quarter worth $131,000. Finally, SRS Capital Advisors Inc. acquired a new stake in Colgate-Palmolive Company during the fourth quarter worth $132,000. Institutional investors own 73.24% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive Company (NYSE:CL) opened at 77.16 on Thursday. The firm has a market capitalization of $68.15 billion, a PE ratio of 27.85 and a beta of 0.70. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The stock’s 50 day moving average price is $73.75 and its 200 day moving average price is $70.43.

Colgate-Palmolive Company (NYSE:CL) last issued its quarterly earnings data on Friday, April 28th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.01. The business had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.80 billion. During the same period last year, the business earned $0.63 earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis. Analysts expect that Colgate-Palmolive Company will post $2.92 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Beaumont Financial Partners LLC Takes Position in Colgate-Palmolive Company (CL)” was originally reported by Mideast Time and is owned by of Mideast Time. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.mideasttime.com/beaumont-financial-partners-llc-takes-position-in-colgate-palmolive-company-cl/1761816.html.

A number of analysts have recently weighed in on CL shares. Zacks Investment Research raised Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a research report on Friday, March 24th. BNP Paribas raised Colgate-Palmolive Company from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 21st. JPMorgan Chase & Co. started coverage on Colgate-Palmolive Company in a research report on Tuesday, March 21st. They set a “neutral” rating and a $77.00 price target for the company. Bank of America Corp lifted their price objective on Colgate-Palmolive Company from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. Finally, Vetr lowered Colgate-Palmolive Company from a “hold” rating to a “sell” rating and set a $69.00 price objective for the company. in a research note on Monday, February 20th. Fourteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $75.41.

In other news, Director Richard J. Kogan sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $71.92, for a total transaction of $575,360.00. Following the completion of the transaction, the director now directly owns 73,065 shares of the company’s stock, valued at approximately $5,254,834.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Daniel B. Marsili sold 14,000 shares of the firm’s stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $73.97, for a total transaction of $1,035,580.00. Following the transaction, the vice president now directly owns 73,904 shares of the company’s stock, valued at $5,466,678.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,833 shares of company stock valued at $2,894,929. Corporate insiders own 1.05% of the company’s stock.

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “CL”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.